Evidence map›Paper›PMID 24718280›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2014

Associations between estrogen receptor-negative breast cancer and timing of reproductive events differ between African American and European American women.

Christine B Ambrosone, Gary R Zirpoli, Dana Howard Bovbjerg, Jyoti Shankar, Chi-Chen Hong, Susan E McCann, Melanie Ruszczyk, Thaer Khoury, Song Yao, Gregory L Ciupak and 3 more

Open access · greenAbstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Breast Cancer Risk in Women from Ghana Carrying Rare Germline Pathogenic Mutations.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2022
    Article
  3. Prevalence, risk factors, and trajectories of sleep disturbance in a cohort of African-American breast cancer survivors.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Article
  4. Knowledge of the Relationship Between Breastfeeding and Breast Cancer Risk Among Racial and Ethnic Minority Women.Journal of cancer education : the official journal of the American Association for Cancer Education · 2020
    Article
  5. Article
  6. Article
  7. FOXA1 Protein Expression in ERCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2020
    Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Christine B AmbrosoneAuthors' Affiliations: Departments of Cancer Prevention and Control and Pathology, Roswell Park Cancer Institute, Buffalo; Icahn School of Medicine at Mount Sinai, New York, New York; University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania; J. Craig Venter Institute, Rockville, Maryland; New Jersey State Cancer Registry, New Jersey Department of Health, Trenton; Rutgers Cancer Institute of New Jersey, New Brunswick; and Rutgers School of Public Health, Piscataway, New Jersey Christine.ambrosone@roswellpark.org.
Gary R ZirpoliAuthors' Affiliations: Departments of Cancer Prevention and Control and Pathology, Roswell Park Cancer Institute, Buffalo; Icahn School of Medicine at Mount Sinai, New York, New York; University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania; J. Craig Venter Institute, Rockville, Maryland; New Jersey State Cancer Registry, New Jersey Department of Health, Trenton; Rutgers Cancer Institute of New Jersey, New Brunswick; and Rutgers School of Public Health, Piscataway, New Jersey.
Dana Howard BovbjergAuthors' Affiliations: Departments of Cancer Prevention and Control and Pathology, Roswell Park Cancer Institute, Buffalo; Icahn School of Medicine at Mount Sinai, New York, New York; University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania; J. Craig Venter Institute, Rockville, Maryland; New Jersey State Cancer Registry, New Jersey Department of Health, Trenton; Rutgers Cancer Institute of New Jersey, New Brunswick; and Rutgers School of Public Health, Piscataway, New Jersey.
Jyoti ShankarAuthors' Affiliations: Departments of Cancer Prevention and Control and Pathology, Roswell Park Cancer Institute, Buffalo; Icahn School of Medicine at Mount Sinai, New York, New York; University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania; J. Craig Venter Institute, Rockville, Maryland; New Jersey State Cancer Registry, New Jersey Department of Health, Trenton; Rutgers Cancer Institute of New Jersey, New Brunswick; and Rutgers School of Public Health, Piscataway, New JerseyAuthors' Affiliations: Departments of Cancer Prevention and Control and Pathology, Roswell Park Cancer Institute, Buffalo; Icahn School of Medicine at Mount Sinai, New York, New York; University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania; J. Craig Venter Institute, Rockville, Maryland; New Jersey State Cancer Registry, New Jersey Department of Health, Trenton; Rutgers Cancer Institute of New Jersey, New Brunswick; and Rutgers School of Public Health, Piscataway, New Jersey.
Chi-Chen HongAuthors' Affiliations: Departments of Cancer Prevention and Control and Pathology, Roswell Park Cancer Institute, Buffalo; Icahn School of Medicine at Mount Sinai, New York, New York; University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania; J. Craig Venter Institute, Rockville, Maryland; New Jersey State Cancer Registry, New Jersey Department of Health, Trenton; Rutgers Cancer Institute of New Jersey, New Brunswick; and Rutgers School of Public Health, Piscataway, New Jersey.
Susan E McCannAuthors' Affiliations: Departments of Cancer Prevention and Control and Pathology, Roswell Park Cancer Institute, Buffalo; Icahn School of Medicine at Mount Sinai, New York, New York; University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania; J. Craig Venter Institute, Rockville, Maryland; New Jersey State Cancer Registry, New Jersey Department of Health, Trenton; Rutgers Cancer Institute of New Jersey, New Brunswick; and Rutgers School of Public Health, Piscataway, New Jersey.
Melanie RuszczykAuthors' Affiliations: Departments of Cancer Prevention and Control and Pathology, Roswell Park Cancer Institute, Buffalo; Icahn School of Medicine at Mount Sinai, New York, New York; University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania; J. Craig Venter Institute, Rockville, Maryland; New Jersey State Cancer Registry, New Jersey Department of Health, Trenton; Rutgers Cancer Institute of New Jersey, New Brunswick; and Rutgers School of Public Health, Piscataway, New Jersey.
Thaer KhouryAuthors' Affiliations: Departments of Cancer Prevention and Control and Pathology, Roswell Park Cancer Institute, Buffalo; Icahn School of Medicine at Mount Sinai, New York, New York; University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania; J. Craig Venter Institute, Rockville, Maryland; New Jersey State Cancer Registry, New Jersey Department of Health, Trenton; Rutgers Cancer Institute of New Jersey, New Brunswick; and Rutgers School of Public Health, Piscataway, New Jersey.
Song YaoAuthors' Affiliations: Departments of Cancer Prevention and Control and Pathology, Roswell Park Cancer Institute, Buffalo; Icahn School of Medicine at Mount Sinai, New York, New York; University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania; J. Craig Venter Institute, Rockville, Maryland; New Jersey State Cancer Registry, New Jersey Department of Health, Trenton; Rutgers Cancer Institute of New Jersey, New Brunswick; and Rutgers School of Public Health, Piscataway, New Jersey.
Gregory L CiupakAuthors' Affiliations: Departments of Cancer Prevention and Control and Pathology, Roswell Park Cancer Institute, Buffalo; Icahn School of Medicine at Mount Sinai, New York, New York; University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania; J. Craig Venter Institute, Rockville, Maryland; New Jersey State Cancer Registry, New Jersey Department of Health, Trenton; Rutgers Cancer Institute of New Jersey, New Brunswick; and Rutgers School of Public Health, Piscataway, New Jersey.
Lina JandorfAuthors' Affiliations: Departments of Cancer Prevention and Control and Pathology, Roswell Park Cancer Institute, Buffalo; Icahn School of Medicine at Mount Sinai, New York, New York; University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania; J. Craig Venter Institute, Rockville, Maryland; New Jersey State Cancer Registry, New Jersey Department of Health, Trenton; Rutgers Cancer Institute of New Jersey, New Brunswick; and Rutgers School of Public Health, Piscataway, New Jersey.
Karen S PawlishAuthors' Affiliations: Departments of Cancer Prevention and Control and Pathology, Roswell Park Cancer Institute, Buffalo; Icahn School of Medicine at Mount Sinai, New York, New York; University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania; J. Craig Venter Institute, Rockville, Maryland; New Jersey State Cancer Registry, New Jersey Department of Health, Trenton; Rutgers Cancer Institute of New Jersey, New Brunswick; and Rutgers School of Public Health, Piscataway, New Jersey.
Elisa V BanderaAuthors' Affiliations: Departments of Cancer Prevention and Control and Pathology, Roswell Park Cancer Institute, Buffalo; Icahn School of Medicine at Mount Sinai, New York, New York; University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania; J. Craig Venter Institute, Rockville, Maryland; New Jersey State Cancer Registry, New Jersey Department of Health, Trenton; Rutgers Cancer Institute of New Jersey, New Brunswick; and Rutgers School of Public Health, Piscataway, New JerseyAuthors' Affiliations: Departments of Cancer Prevention and Control and Pathology, Roswell Park Cancer Institute, Buffalo; Icahn School of Medicine at Mount Sinai, New York, New York; University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania; J. Craig Venter Institute, Rockville, Maryland; New Jersey State Cancer Registry, New Jersey Department of Health, Trenton; Rutgers Cancer Institute of New Jersey, New Brunswick; and Rutgers School of Public Health, Piscataway, New Jersey.
UPMC Hillman Cancer Center · USRutgers Cancer Institute of New JerseyNew Jersey Department of Health · USRoswell Park Comprehensive Cancer Center · USRutgers, The State University of New Jersey · US

Funding

Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI MARK G FRATTINI · 1985 to 2026
$116.6M
TRANSCRIPTIONAL PROFILINGP30CA072720 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI Chang S Chan · 1997 to 2026
$94.5M
Reproduction, Lactation and Hormonal Factors in Breast Cancer SubtypesP01CA151135 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI AMBROSONE, CHRISTINE B., OLSHAN, ANDREW · 2011 to 2017
$18.1M
Race &Risk Factors for Early/Aggressive Breast CancerR01CA100598 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI AMBROSONE, CHRISTINE B. · 2004 to 2008
$4.8M
Obesity in ovarian cancer prognosisK22CA138563 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI BANDERA, ELISA V · 2010 to 2012
$605k
NCCDPHP CDC HHS U58 DP003931NCI NIH HHS K22 CA138563NCI NIH HHS P01 CA151135NCI NIH HHS P30 CA016056NCI NIH HHS P30 CA072720NCI NIH HHS R01 CA100598
6 · The paper itself

Abstract

The effects of reproductive factors on breast cancer risk seem to differ by estrogen receptor (ER) status. Menarche and first live birth (FLB) tend to occur at younger ages in African Americans (AA) than European Americans (EA), and could play a role in breast cancer disparities. In the Women's Circle of Health Study, a case-control study of breast cancer in EA and AA women, in-person interviews were conducted to collect epidemiologic data, including reproductive histories. Data on ER status, abstracted from pathology reports, were available for 814 AA and 538 EA breast cancer cases, and were analyzed with 1015 AA and 715 EA controls, to evaluate associations between subgroups and age at menarche, age at FLB, and the interval between those ages. Among AA women, later age at menarche (≥14 years) was associated with reduced risk of both ER(+) and ER(-) breast cancer, with ORs strongest for ER(-) disease [OR = 0.57; 95% confidence interval (CI), 0.37-0.88]; associations were weaker and nonsignificant for EA women. There were no significant associations with age at FLB, but AA women with a FLB within 15 years of menarche had increased risk of ER(-) disease (OR = 2.26; 95% CI, 1.29-3.95), with no significant associations among EAs. In our data, earlier age at menarche and shorter intervals until FLB are associated with ER(-) breast cancer in AA women; differential distributions by race of these and other reproductive risk factors could contribute to the higher prevalence of ER(-) breast cancer in AA women. Cancer Epidemiol Biomarkers Prev; 23(6); 1115-20. ©2014 AACR.

Indexed as

AdultBlack or African AmericanBreast NeoplasmsFemaleGenetic Predisposition to DiseaseHumansMiddle AgedPrognosisReproductionRisk FactorsWhite People

Identifiers

PMID24718280
PMCPMC4058775
OpenAlexW2168702754

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.